Boston Scientific to acquire Apama Medical for up to $300 million

Boston Scientific has agreed to acquire Apama Medical, a developer of the Apama Radiofrequency Balloon Catheter System for treating atrial fibrillation, for $175 million upfront plus up to $125 million in contingent payments.

“The acquisition of Apama further advances our continued investment in the electrophysiology category, and, upon commercialization, would broaden our portfolio of differentiated arrhythmia solutions.”news.bostonscientific.com

• 1 source
• news.bostonscientific.comBoston Scientific Announces Agreement to Acquire Apama MedicalOct 2, 2017

Summarized from public sources; check the original articles before acting on it.